Lan et al. (2017a) reported a series of cinnamic acid derivatives to be multifunctional cholinesterase inhibitors against AD by linking to the N-benzylpyridinium part and diverse substituted cinnamic acids (Supplementary Scheme S36). The gene discussed is BCHE; the disease is Alzheimer disease.